Earnings · China A-shares
Suzhou Fushilai Pharmaceutical Co., Ltd. Class A (301258) earnings
Suzhou Fushilai Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-22: net profit -151.89% year on year, -1805.17% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -5.65% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-22
- Period end
- 2026-09-30
- Net profit YoY
- -151.89%
- Excl. one-offs YoY
- -1805.17%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.65% | — |
| 3 days | -5.65% | — |
| 7 days | -9.02% | — |
| 14 days | -3.46% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -0.32%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-23 | -¥38.09M | -151.89% | — | -17.84% | -0.43 | -2.07% | -5.65% | — | — |
| 2026 interim report | 2026-08-25 | -¥14.62M | -133.93% | — | -17.17% | -0.17 | -0.79% | +0.38% | +1.77% | +7.79% |
| 2026 Q1 report | 2026-04-23 | -¥2.77M | -111.56% | — | -17.88% | -0.03 | -0.15% | -8.80% | -22.85% | -21.30% |
| 2025 annual report | 2026-04-23 | ¥64.29M | +291.89% | +63.37% | +0.76% | 0.71 | 3.39% | -8.80% | -22.85% | -21.30% |
| 2025 Q3 report | 2025-10-24 | ¥73.40M | +430.16% | +119.80% | +3.23% | 0.81 | 3.83% | -2.14% | -9.71% | -9.48% |
| 2025 interim report | 2025-08-22 | ¥43.08M | +12430.96% | +226.38% | +3.36% | 0.47 | 2.26% | -1.94% | -9.01% | -16.80% |
| 2025 Q1 report | 2025-04-22 | ¥23.94M | +313.65% | -39.17% | +17.44% | 0.26 | 1.26% | +16.25% | +25.91% | +23.04% |
| 2024 annual report | 2025-04-22 | ¥16.41M | -85.38% | — | -12.23% | 0.18 | 0.85% | +16.25% | +25.91% | +23.04% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.